A Phase-IV, Multi-centric, Open Label, Comparative Clinical Trial to Evaluate Safety, Tolerability, and Efficacy of Oral Tablets of Fixed-dose Combination of Alogliptin and Metformin Hydrochloride versus Alogliptin in the Treatment of Indian Type-2 Diabetes Mellitus Patients: CONFIDENCE Trial
Introduction: Dipeptidyl peptidase-4 inhibitors are widely used antidiabetic drugs due to their convenient dosing, modest HbA1C reduction, and minimal risk of hypoglycemia, commonly prescribed in combination with metformin. A phase-IV, multi-centric, open-label, randomized, comparative clinical tria...
Shranjeno v:
| Principais autores: | , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Wolters Kluwer Medknow Publications
2025-01-01
|
| Serija: | Chronicle of Diabetes Research and Practice |
| Teme: | |
| Online dostop: | https://journals.lww.com/10.4103/cdrp.cdrp_5_24 |
| Oznake: |
Brez oznak, prvi označite!
|